CAS 168626-94-6
:Cloridrato di conivaptan
Descrizione:
Cloridrato di conivaptan è un composto sintetico classificato come un antagonista duale dei recettori della vasopressina, che agisce specificamente sui recettori V1A e V2. È utilizzato principalmente nel trattamento di condizioni associate a iponatremia, in particolare nei pazienti con insufficienza cardiaca o sindrome da secrezione inadeguata di ormone antidiuretico (SIADH). La sostanza è tipicamente somministrata per via endovenosa ed è nota per la sua capacità di promuovere l'aquaresi, che è l'escrezione di acqua libera senza la perdita di elettroliti. Cloridrato di conivaptan è caratterizzato dalla sua relativamente bassa solubilità in acqua, il che può influenzare la sua formulazione e i metodi di somministrazione. Il composto ha una struttura molecolare specifica che contribuisce alla sua attività farmacologica ed è metabolizzato principalmente nel fegato, con una emivita che consente regimi di dosaggio efficaci. Come per qualsiasi farmaco, gli effetti collaterali potenziali possono includere ipotensione, squilibri elettrolitici e reazioni nel sito di infusione, richiedendo un attento monitoraggio durante il trattamento.
Formula:C32H26N4O2·HCl
InChI:InChI=1/C32H26N4O2.ClH/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22;/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37);1H
InChI key:InChIKey=BTYHAFSDANBVMJ-UHFFFAOYSA-N
SMILES:C(=O)(N1C=2C(C3=C(CC1)N=C(C)N3)=CC=CC2)C4=CC=C(NC(=O)C5=C(C=CC=C5)C6=CC=CC=C6)C=C4.Cl
Sinonimi:- Conivaptan Monohydrochloride
- N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride
- N-{4-[(2-Methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamidhydrochlorid
- N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride
- N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(3H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride (1:1)
- N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazépin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide chlorhydrate
- Vaprisol
- Ym 087
- [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride
- [1,1′-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1)
- Conivaptan hydrochloride
- N-[4-[(4,5-Dihydro-2-MethyliMidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-Biphenyl]-2-carboxaMide Hydrochloride
- N-(4-(2-methyl-3,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride
- Conivaptan hydrochkoride
- Conivaptan Hydrochloride Q: What is the CAS Number of
- Conivaptan HCl
- Conivaptan HydrochlorideQ: What is
- Conivaptan HCI
- N-[4-(2-Methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride
- Conivaptan hydrochloride [usan]
- Conivaptan Hydrochloride Q: What is the storage condition of
- Conivaptan Hydrochloride Q: What are the applications of
- N-[4-(2-Methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamid
- Unii-75L57R6X36
- Conivaptan hydrochloride USP/EP/BP
- N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][benzazepin-6(1H)-yl)carbonyl]phenyl-[1,1'-biphenyl]-2-carboxamide hydrochloride
- Conivaptan hydrochloride, >=99%
- [1,1'-Biphenyl]-2-carboxamide,N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,hydrochloride
- N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide, hydrochloride (1:1)
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 prodotti.
[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1)
CAS:Formula:C32H27ClN4O2Purezza:98%Colore e forma:SolidPeso molecolare:535.0354Conivaptan HCl
CAS:Formula:C32H26N4O2·HClColore e forma:White To Off-White SolidPeso molecolare:498.59 36.46Conivaptan Hydrochloride
CAS:Prodotto controllatoFormula:C32H26N4O2·ClHColore e forma:NeatPeso molecolare:535.04Conivaptan hydrochloride
CAS:<p>Conivaptan hydrochloride (Vaprisol) is an orally active vasopressin V2 and V1A receptor antagonist, used in the therapy of hypervolemic hyponatremia and</p>Formula:C32H26N4O2·HClPurezza:98.33% - 99.86%Colore e forma:SolidPeso molecolare:535.04Conivaptan Hydrochloride
CAS:Prodotto controllato<p>Applications Used in treatment of congestive heart failure.<br>References Mao, Z., et al.: Clin. Ther., 31, 1542 (2009), Arai, Y., et al.: J. Pharm. Sci., 109, 53 (2009),<br></p>Formula:C32H26N4O2·ClHColore e forma:NeatPeso molecolare:535.04Conivaptan hydrochloride
CAS:Prodotto controllato<p>Conivaptan hydrochloride is a selective, orally active vasopressin receptor antagonist that has been shown to be effective in the treatment of congestive heart failure. Conivaptan hydrochloride is used in experimental models to study its efficacy and safety. The long-term efficacy of conivaptan hydrochloride was demonstrated in a chronic oral study with rats. Optimum concentrations for conivaptan hydrochloride are between 0.5 and 2 mg/kg body weight, which should be administered three times daily. In patients with hepatic impairment, the concentration–time curve of conivaptan hydrochloride may be affected so that higher doses are required to achieve the desired effect. This drug also interacts with drugs such as warfarin, beta blockers, or calcium channel blockers. Patients with high body mass index or systolic pressure should not use this medication because it can lead to serious side effects.</p>Formula:C32H27ClN4O2Purezza:Min. 95%Colore e forma:White PowderPeso molecolare:535.04 g/mol







